A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Public ClinicalTrials.gov record NCT06096779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Open-label, Multi-cohort, Multicenter Study in Patients With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety of atezolizumab and bevacizumab, or atezolizumab alone, as first-line treatment in participants with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-pugh B7 or B8 cirrhosis.
Study identification
- NCT ID
- NCT06096779
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 30 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 15, 2024 (Actual)
- Primary completion
- Jul 30, 2027 (Estimated)
- Completion
- Dec 30, 2027 (Estimated)
- Last update posted
- Oct 8, 2026
2024 – 2027
United States locations
- U.S. sites
- 53
- U.S. states
- 23
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| UC San Diego Moores Cancer Center | La Jolla | California | 92093 | — |
| University of Southern California-Keck School of Medicine -1975 Zonal Ave | Los Angeles | California | 90089-5601 | — |
| University of Southern California | Newport Beach | California | 92663 | — |
| University of California Irvine Medical Center | Orange | California | 92868 | — |
| California Liver Research Institute | Pasadena | California | 91105-2561 | — |
| University of California Davis Medical Center | Sacramento | California | 95817 | — |
| Stanford Health Care | Stanford | California | 94305 | — |
| Harbor UCLA Medical Center | Torrance | California | 90502-2006 | — |
| Cedars Sinai Comprehensive Transplant Center | West Hollywood | California | 90048-2422 | — |
| Hartford Healthcare Cancer Institute at Hartford Hospital | Hartford | Connecticut | 06106 | — |
| George Washington University- Medical Faculty Associates | Washington D.C. | District of Columbia | 20037 | — |
| Washington DC VA Medical Center | Washington D.C. | District of Columbia | 20422-0001 | — |
| Orlando Health Inc. | Orlando | Florida | 32806 | — |
| Northwestern University | Chicago | Illinois | 60611-2908 | — |
| University of Illinois Health Outpatient Care Center | Chicago | Illinois | 60612-4795 | — |
| The Duchossois Center for Advanced Medicine | Chicago | Illinois | 60637-1426 | — |
| University of Kentucky - Markey Cancer Center | Lexington | Kentucky | 40536-7001 | — |
| LSU Health Baton Rouge | Baton Rouge | Louisiana | 70805 | — |
| Our Lady of the Lake Cancer Institute | Baton Rouge | Louisiana | 70808-4300 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| Beth Israel Deaconess Medical Center | Boston | Massachusetts | 02215 | — |
| Barbara Ann Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Saint Luke?s Hospital of Kansas City | Kansas City | Missouri | 64111 | — |
| Rutgers Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | — |
| Rutgers Cancer Institute of New Jersey at University Hospital | Newark | New Jersey | 07103 | — |
| NYU Langone Hospital - Long Island | Mineola | New York | 11501-4064 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| James J Peters Veterans Administration Medical Center - NAVREF | The Bronx | New York | 10468-3904 | — |
| Levine Cancer Institute | Charlotte | North Carolina | 28204 | — |
| Dayton VA Medical Center - NAVREF - PPDS | Dayton | Ohio | 45428-9000 | — |
| The University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104-5020 | — |
| Kaiser Permanente Westside Medical Center | Hillsboro | Oregon | 97124-5806 | — |
| OHSU Knight Cancer Institute Hematology Oncology | Portland | Oregon | 97239-3011 | — |
| Jefferson Health Honickman Center | Philadelphia | Pennsylvania | 19107 | — |
| Veterans Affairs Pittsburgh Healthcare System - NAVREF - PPDS | Pittsburgh | Pennsylvania | 15240 | — |
| The West Clinic (East Campus) | Germantown | Tennessee | 38138-1762 | — |
| Nashville General Hospital at Meharry | Nashville | Tennessee | 37208-2918 | — |
| Liver Institute at Methodist Dallas | Dallas | Texas | 75203-1260 | — |
| Moody Outpatient Center ? Parkland Health | Dallas | Texas | 75235 | — |
| Texas Oncology (Worth) - USOR | Dallas | Texas | 75246-2008 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-0001 | — |
| Texas Oncology - Denison Cancer Center | Denison | Texas | 75020-0084 | — |
| Kelsey Research Foundation | Houston | Texas | 77025-1669 | — |
| Michael E Debakey VA Medical Center - NAVREF - PPDS | Houston | Texas | 77030-4211 | — |
| Intermountain Healthcare | Murray | Utah | 84107-5741 | — |
| Intermountain Cancer Center | St. George | Utah | 84790 | — |
| Inova Schar Cancer Institute | Falls Church | Virginia | 22042 | — |
| Bon Secours St. Mary's Hospital | Richmond | Virginia | 23226-1925 | — |
| VCU Medical Center North Hospital | Richmond | Virginia | 23298-5028 | — |
| Virginia Mason Medical Center | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06096779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 8, 2026 · Synced Nov 3, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06096779 live on ClinicalTrials.gov.